These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15934835)
21. Radioimmunotherapy in follicular lymphoma. Illidge T; Morschhauser F Best Pract Res Clin Haematol; 2011 Jun; 24(2):279-93. PubMed ID: 21658624 [TBL] [Abstract][Full Text] [Related]
22. Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab. Hohenstein MA; Augustine SC; Rutar F; Vose JM Semin Oncol; 2003 Apr; 30(2 Suppl 4):39-49. PubMed ID: 12728406 [TBL] [Abstract][Full Text] [Related]
23. Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomas. Capizzi RL Trans Am Clin Climatol Assoc; 2004; 115():255-72. PubMed ID: 17060972 [TBL] [Abstract][Full Text] [Related]
24. Tositumomab and iodine [131I] tositumomab in the management of follicular lymphoma. An oncologist's view. Davies AJ Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):305-16. PubMed ID: 15640794 [TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II study. Link BK; Martin P; Kaminski MS; Goldsmith SJ; Coleman M; Leonard JP J Clin Oncol; 2010 Jun; 28(18):3035-41. PubMed ID: 20458031 [TBL] [Abstract][Full Text] [Related]
26. The radioisotope contributes significantly to the activity of radioimmunotherapy. Davis TA; Kaminski MS; Leonard JP; Hsu FJ; Wilkinson M; Zelenetz A; Wahl RL; Kroll S; Coleman M; Goris M; Levy R; Knox SJ Clin Cancer Res; 2004 Dec; 10(23):7792-8. PubMed ID: 15585610 [TBL] [Abstract][Full Text] [Related]
27. Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens. Nordøy T; Kolstad A; Tuck MK; Aaberge IS; Husebekk A; Kaminski MS Clin Immunol; 2001 Jul; 100(1):40-8. PubMed ID: 11414744 [TBL] [Abstract][Full Text] [Related]
28. Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. Dillman RO Curr Hematol Rep; 2003 Jan; 2(1):30-7. PubMed ID: 12901152 [TBL] [Abstract][Full Text] [Related]
29. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911. Press OW; Unger JM; Braziel RM; Maloney DG; Miller TP; Leblanc M; Fisher RI; J Clin Oncol; 2006 Sep; 24(25):4143-9. PubMed ID: 16896003 [TBL] [Abstract][Full Text] [Related]
30. Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma: preliminary report. Koral KF; Dewaraja Y; Clarke LA; Li J; Zasadny KR; Rommelfanger SG; Francis IR; Kaminski MS; Wahl RL Cancer Biother Radiopharm; 2000 Aug; 15(4):347-55. PubMed ID: 11041019 [TBL] [Abstract][Full Text] [Related]
31. Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. Kaminski MS; Zelenetz AD; Press OW; Saleh M; Leonard J; Fehrenbacher L; Lister TA; Stagg RJ; Tidmarsh GF; Kroll S; Wahl RL; Knox SJ; Vose JM J Clin Oncol; 2001 Oct; 19(19):3918-28. PubMed ID: 11579112 [TBL] [Abstract][Full Text] [Related]
32. Use of iodine 131I-tositumomab radioimmunotherapy in a patient with Waldenstrom's macroglobulinemia. Tsai DE; Maillard I; Downs LH; Alavi A; Nasta SD; Glatstein E; Schuster SJ Leuk Lymphoma; 2004 Mar; 45(3):591-5. PubMed ID: 15160923 [TBL] [Abstract][Full Text] [Related]
33. High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma. Gopal AK; Rajendran JG; Gooley TA; Pagel JM; Fisher DR; Petersdorf SH; Maloney DG; Eary JF; Appelbaum FR; Press OW J Clin Oncol; 2007 Apr; 25(11):1396-402. PubMed ID: 17312330 [TBL] [Abstract][Full Text] [Related]
35. Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin's lymphoma. Meredith RF Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S23-9. PubMed ID: 16979435 [TBL] [Abstract][Full Text] [Related]
36. Clinical development of radioimmunotherapy for B-cell non-Hodgkin's lymphoma. Meredith RF; Knox SJ Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S15-22. PubMed ID: 16979433 [TBL] [Abstract][Full Text] [Related]
37. Bexxar, iodine I 131 tositumomab, effective in long-term follow-up of non-Hodgkin's lymphoma. Kaminski M Cancer Biol Ther; 2007 Jul; 6(7):996-7. PubMed ID: 19358342 [No Abstract] [Full Text] [Related]
38. Radioimmunotherapy in follicular lymphoma: some like it hot…. Kersten MJ Transfus Apher Sci; 2011 Apr; 44(2):173-8. PubMed ID: 21334979 [TBL] [Abstract][Full Text] [Related]
39. Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas. Vose JM; Wahl RL; Saleh M; Rohatiner AZ; Knox SJ; Radford JA; Zelenetz AD; Tidmarsh GF; Stagg RJ; Kaminski MS J Clin Oncol; 2000 Mar; 18(6):1316-23. PubMed ID: 10715303 [TBL] [Abstract][Full Text] [Related]